{"id":"https://openalex.org/W1563530802","doi":"https://doi.org/10.5772/25787","title":"Optimal Treatment Strategy for Amyloid A Amyloidosis in Rheumatic Diseases \u2013 Anti-Interleukin-6 Receptor Therapy","display_name":"Optimal Treatment Strategy for Amyloid A Amyloidosis in Rheumatic Diseases \u2013 Anti-Interleukin-6 Receptor Therapy","publication_year":2011,"publication_date":"2011-12-22","ids":{"openalex":"https://openalex.org/W1563530802","doi":"https://doi.org/10.5772/25787","mag":"1563530802"},"language":"en","primary_location":{"id":"doi:10.5772/25787","doi":"https://doi.org/10.5772/25787","is_oa":true,"landing_page_url":"https://doi.org/10.5772/25787","pdf_url":"https://www.intechopen.com/citation-pdf-url/25474","source":{"id":"https://openalex.org/S4306463447","display_name":"InTech eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Challenges in Rheumatology","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W2505366142","display_name":"Challenges in Rheumatology"},"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.intechopen.com/citation-pdf-url/25474","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102105238","display_name":"Yasuaki Okuda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128702","display_name":"Dogo Onsen Hospital","ror":"https://ror.org/031dgzs07","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210128702"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yasuaki Okuda","raw_affiliation_strings":["Center for Rheumatic Diseases , Dohgo Spa Hospital Japan www","Department of Internal Medicine,","Center for Rheumatic Diseases, Dohgo Spa Hospital Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Rheumatic Diseases , Dohgo Spa Hospital Japan www","institution_ids":["https://openalex.org/I4210128702"]},{"raw_affiliation_string":"Department of Internal Medicine,","institution_ids":[]},{"raw_affiliation_string":"Center for Rheumatic Diseases, Dohgo Spa Hospital Japan","institution_ids":["https://openalex.org/I4210128702"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5102105238"],"corresponding_institution_ids":["https://openalex.org/I4210128702"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.03326544,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":0.9624000191688538,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":0.9624000191688538,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.013700000010430813,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.00800000037997961,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amyloid-a-amyloidosis","display_name":"amyloid A amyloidosis","score":0.9539999961853027},{"id":"https://openalex.org/keywords/rheumatic-diseases","display_name":"rheumatic diseases","score":0.972000002861023},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.777999997138977},{"id":"https://openalex.org/keywords/treatment-strategy","display_name":"treatment options","score":0.8669999837875366},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.6899999976158142}],"concepts":[{"id":"https://openalex.org/C2777007455","wikidata":"https://www.wikidata.org/wiki/Q2844591","display_name":"AA amyloidosis","level":4,"score":0.864227294921875},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8385381698608398},{"id":"https://openalex.org/C55359608","wikidata":"https://www.wikidata.org/wiki/Q3113038","display_name":"Serum amyloid A","level":3,"score":0.802348256111145},{"id":"https://openalex.org/C2779951007","wikidata":"https://www.wikidata.org/wiki/Q816798","display_name":"Amyloidosis","level":2,"score":0.7908551096916199},{"id":"https://openalex.org/C2777178219","wikidata":"https://www.wikidata.org/wiki/Q425154","display_name":"Tocilizumab","level":3,"score":0.5850141048431396},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.5428126454353333},{"id":"https://openalex.org/C2910060150","wikidata":"https://www.wikidata.org/wiki/Q3113038","display_name":"Serum Amyloid A Protein","level":4,"score":0.5153064727783203},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5099023580551147},{"id":"https://openalex.org/C57194454","wikidata":"https://www.wikidata.org/wiki/Q424211","display_name":"Acute-phase protein","level":3,"score":0.5035268664360046},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.49339738488197327},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.49330440163612366},{"id":"https://openalex.org/C2776760755","wikidata":"https://www.wikidata.org/wiki/Q18939","display_name":"Azathioprine","level":3,"score":0.474812388420105},{"id":"https://openalex.org/C2777633098","wikidata":"https://www.wikidata.org/wiki/Q2736051","display_name":"Amyloid (mycology)","level":2,"score":0.4692656397819519},{"id":"https://openalex.org/C2776715498","wikidata":"https://www.wikidata.org/wiki/Q11426176","display_name":"Prednisolone","level":2,"score":0.4410082697868347},{"id":"https://openalex.org/C2779551797","wikidata":"https://www.wikidata.org/wiki/Q4652470","display_name":"AL amyloidosis","level":4,"score":0.43361231684684753},{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.42855826020240784},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3997688591480255},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.2903921604156494},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.23963141441345215},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.23145779967308044},{"id":"https://openalex.org/C2779537928","wikidata":"https://www.wikidata.org/wiki/Q1144618","display_name":"Familial Mediterranean fever","level":3,"score":0.216612309217453},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.21238163113594055},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.19355180859565735},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1294270157814026},{"id":"https://openalex.org/C36394416","wikidata":"https://www.wikidata.org/wiki/Q949267","display_name":"Immunoglobulin light chain","level":3,"score":0.09061369299888611}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.5772/25787","doi":"https://doi.org/10.5772/25787","is_oa":true,"landing_page_url":"https://doi.org/10.5772/25787","pdf_url":"https://www.intechopen.com/citation-pdf-url/25474","source":{"id":"https://openalex.org/S4306463447","display_name":"InTech eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Challenges in Rheumatology","raw_type":"book-chapter"},{"id":"pmh:oai:biblioboard.com:fca70d3c-83e1-4c36-a9d1-e674e214ef1d","doi":null,"is_oa":true,"landing_page_url":"https://openresearchlibrary.org/viewer/fca70d3c-83e1-4c36-a9d1-e674e214ef1d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401131","display_name":"BiblioBoard Library Catalog (Open Research Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"MODID-6d55e02e354:IntechOpen","raw_type":"CHAPTER"},{"id":"pmh:oai:intechopen.com:25474","doi":null,"is_oa":true,"landing_page_url":"http://www.intechopen.com/articles/show/title/optimal-treatment-strategy-for-amyloid-a-amyloidosis-in-rheumatic-diseases-anti-interleukin-6-recept","pdf_url":null,"source":{"id":"https://openalex.org/S4306401291","display_name":"Contact-less Assessment of In-vivo Body Signals Using Microwave Doppler Radar (InTech)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210154139","host_organization_name":"Intech (Slovakia)","host_organization_lineage":["https://openalex.org/I4210154139"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.intechopen.com/download/pdf/pdfs_id/25474","raw_type":"09"}],"best_oa_location":{"id":"doi:10.5772/25787","doi":"https://doi.org/10.5772/25787","is_oa":true,"landing_page_url":"https://doi.org/10.5772/25787","pdf_url":"https://www.intechopen.com/citation-pdf-url/25474","source":{"id":"https://openalex.org/S4306463447","display_name":"InTech eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Challenges in Rheumatology","raw_type":"book-chapter"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321945","display_name":"Ministry of Health, Labour and Welfare","ror":"https://ror.org/03mwa7s65"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1563530802.pdf","grobid_xml":"https://content.openalex.org/works/W1563530802.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W136266896","https://openalex.org/W1479791469","https://openalex.org/W1675597915","https://openalex.org/W1858080198","https://openalex.org/W1976303194","https://openalex.org/W1987192197","https://openalex.org/W1987578164","https://openalex.org/W1990912960","https://openalex.org/W1997646502","https://openalex.org/W2001939792","https://openalex.org/W2027477057","https://openalex.org/W2027946365","https://openalex.org/W2031556289","https://openalex.org/W2033547195","https://openalex.org/W2041430553","https://openalex.org/W2050409515","https://openalex.org/W2050770867","https://openalex.org/W2064162033","https://openalex.org/W2065028117","https://openalex.org/W2071821847","https://openalex.org/W2085410330","https://openalex.org/W2085917800","https://openalex.org/W2095151808","https://openalex.org/W2103402325","https://openalex.org/W2109646234","https://openalex.org/W2117528554","https://openalex.org/W2120975877","https://openalex.org/W2121715132","https://openalex.org/W2125126585","https://openalex.org/W2128699290","https://openalex.org/W2130682857","https://openalex.org/W2142322879","https://openalex.org/W2152894578","https://openalex.org/W2153764654","https://openalex.org/W2167420624","https://openalex.org/W2168431016","https://openalex.org/W2169325672","https://openalex.org/W4252370835"],"related_works":["https://openalex.org/W4313706632","https://openalex.org/W4245921209","https://openalex.org/W4243640334","https://openalex.org/W2128699290","https://openalex.org/W2900118259","https://openalex.org/W2401800110","https://openalex.org/W2593000540","https://openalex.org/W2334728125","https://openalex.org/W4225728475","https://openalex.org/W2405067294"],"abstract_inverted_index":{"Yasuaki":[0],"Okuda":[1],"(2011).":[2],"Optimal":[3],"Treatment":[4],"Strategy":[5],"for":[6],"Amyloid":[7],"A":[8],"Amyloidosis":[9],"in":[10,16],"Rheumatic":[11],"Diseases":[12],"-Anti-Interleukin-6Receptor":[13],"Therapy,":[14],"Challenges":[15],"Rheumatology,":[17],"Dr.":[18]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}